Mitozz Community Events, Webinars, and Live Q&A View Events ➝

    End of Content.

    Peer-Reviewed Papers

    Explore published research on mitochondrial function, cellular energy, (-)-epicatechin, vascular biology, and related metabolic pathways. Browse by specialization below to quickly find the papers most relevant to your interests.

    Featured Papers

    Improving Cardiovascular Risk in Postmenopausal Women with (−)-Epicatechin

    Nájera et al., 2024 · Journal of Clinical Medicine

    Randomized, double-blind, placebo-controlled proof-of-concept trial evaluating cardiovascular risk–related measures in postmenopausal women using an (−)-epicatechin–enriched cacao supplement.

    View Paper

    Antifibrotic Effects of (−)-Epicatechin in High-Glucose–Stimulated Cardiac Fibroblasts

    Garate-Carrillo et al., 2021 · Journal of Medicinal Food

    Cell-based mechanistic study examining how (−)-epicatechin modulates profibrotic signaling under high-glucose conditions, focusing on GPER and TGF-β1/SMAD pathways.

    View Paper

    Modulation of Chronic Renal Damage Markers by (−)-Epicatechin in a 5/6 Nephrectomy Model

    Montes-Rivera et al., 2019 · Heliyon

    Preclinical study in a progressive chronic kidney disease model assessing the effects of (−)-epicatechin on biomarkers associated with renal injury progression.

    View Paper

    Search Papers by Specialization

    Epicatechin, Mitochondrial Proteins, and Oxidative Stress in Dystrophic Muscle

    Study Title: (-)-Epicatechin improves mitochondrial-related protein levels and ameliorates oxidative stress in dystrophic δ-sarcoglycan null mouse striated muscle

    Citation: Ramirez-Sanchez et al., 2014 · FEBS Journal

    What the Study Found: This mouse study examined whether (-)-epicatechin could improve mitochondrial and oxidative stress markers in dystrophic δ-sarcoglycan null muscle. Researchers treated dystrophic mice with (-)-epicatechin for two weeks and analyzed skeletal and cardiac muscle. The treatment improved several markers related to mitochondrial structure and function, including citrate synthase activity and mitochondrial-related protein levels. It also reduced protein carbonylation, improved glutathione balance, and increased antioxidant enzyme activity. These changes were accompanied by reduced fibrosis and improved skeletal muscle function in the dystrophic mouse model.

    What this means in real life: This study suggests that mitochondrial stress may be an important part of muscle damage in muscular dystrophy models. In these mice, (-)-epicatechin appeared to support mitochondrial-related proteins and redox balance, which may help explain the improvements seen in muscle structure and function. This does not mean (-)-epicatechin treats muscular dystrophy in humans. It does support the broader idea that mitochondrial function, oxidative stress control, and muscle resilience are closely connected.

    Clinical Relevance: Mouse study, dystrophic skeletal and cardiac muscle, mitochondrial-related protein levels, oxidative stress, fibrosis, and muscle function model.

    Related Content:

    View Paper

    Epicatechin and PXR Signaling in Skeletal Muscle

    Study Title: PXR is a target of (-)-epicatechin in skeletal muscle

    Citation: Ortiz-Flores et al., 2020 · Heliyon

    What the Study Found: This study examined whether pregnane X receptor, or PXR, may be one of the molecular targets involved in (-)-epicatechin’s effects on skeletal muscle. The researchers used computational docking, C2C12 muscle cells, and mouse skeletal muscle tissue. Their results showed that (-)-epicatechin interacted with the ligand-binding domain of PXR and influenced PXR-related signaling. In muscle cells and mouse muscle, (-)-epicatechin increased PXR expression and was associated with changes in markers linked to muscle growth, differentiation, and metabolism.

    What this means in real life: This study helps explain a possible pathway through which (-)-epicatechin may influence skeletal muscle biology. Instead of acting only as a general antioxidant, (-)-epicatechin may interact with specific cellular signaling systems, including PXR. This does not mean it treats muscle disease or guarantees muscle growth in humans. It does support the idea that (-)-epicatechin’s effects may involve receptor-linked signaling pathways that help regulate muscle cell activity and metabolic function.

    Clinical Relevance: Cell, computational, and mouse skeletal muscle study, (-)-epicatechin, PXR signaling, muscle growth markers, differentiation, and metabolism model.

    Related Content:

    View Paper

    Chronic Renal Damage, Stress Signaling, and Cellular Protection

    Study Title:
    Effect of (-)-epicatechin on the modulation of progression markers of chronic renal damage in a 5/6 nephrectomy experimental model

    Citation: Montes-Rivera et al., 2019 · Heliyon

    What the Study Found: In a 5/6 nephrectomy rat model of chronic kidney disease, (−)-epicatechin modulated key biomarkers of inflammation, fibrosis, and cellular stress in the kidneys. The treatment altered several disease-progression markers. These changes suggest a slowing of the typical disease progression seen in this model.

    What this means in real life: The kidneys are extremely energy-hungry organs that rely on healthy mitochondria to filter blood and handle daily stress. When mitochondrial function weakens, renal damage can accelerate. This study shows that (−)-epicatechin can positively influence stress-signaling pathways in the kidney, supporting the cellular energy environment needed for long-term renal resilience.

    Related Content:

    View Paper

    Cognitive Recovery, Inflammation, and Mitochondrial Restoration in Gulf War Illness

    Study Title:
    Neurological Restorative Effects of (-)-Epicatechin in a Model of Gulf War Illness

    Citation:
    Ramírez-Sánchez et al., 2024. Journal of Medicinal Food

    What the Study Found:
    In a rat model of Gulf War Illness, (−)-epicatechin improved both short- and long-term memory performance. It reduced hippocampal oxidative stress, neuroinflammation, and markers of cell death. Most notably, treatment fully restored mitochondrial function markers that had been impaired by the illness.

    What this means in real life:
    Gulf War Illness demonstrates how mitochondrial damage can drive persistent brain fog, memory issues, and chronic inflammation. This study clearly shows that (−)-epicatechin can restore mitochondrial function and, in turn, support cognitive recovery. It highlights why mitochondrial health is central to resilience when the brain faces complex, long-term stress.

    Related Content

    View Paper

    Neuroinflammation, Tau Pathology, and Brain Aging

    Study Title: Effects of (−)-epicatechin on neuroinflammation and hyperphosphorylation of tau in the hippocampus of aged mice

    Citation: Navarrete-Yañez et al., 2020 · Food & Function

    What the Study Found: (−)-Epicatechin reduced oxidative stress, neuroinflammation, and tau hyperphosphorylation in the hippocampus of aged mice. These improvements were linked to better markers of cellular health in the brain tissue. The study also reported positive cognitive-related outcomes in the aged model.

    What this means in real life: As mitochondria become less efficient with age, oxidative stress and inflammation can build up and disrupt normal brain proteins such as tau. This study shows that (−)-epicatechin can calm these processes in the hippocampus, helping preserve cellular health where memory is formed. Mitochondrial support is therefore a foundational strategy for maintaining cognitive resilience as we age.

    Related Content:

    View Paper

    Neurogenesis, Short-Term Memory, and Nitric Oxide Signaling

    Study Title:
    Stimulatory effects of (−)-epicatechin and its enantiomer (+)-epicatechin on mouse frontal cortex neurogenesis markers and short-term memory: proof of concept

    Citation:
    Ramirez-Sanchez et al., 2021. Food & Function

    What the Study Found:
    Both (−)-epicatechin and its enantiomer (+)-epicatechin increased markers of neurogenesis (including neuronal growth proteins) in the mouse frontal cortex. The compounds also raised capillary density and enhanced nitric oxide signaling pathways. These biological changes were accompanied by measurable improvements in short-term memory performance.

    What this means in real life:
    Neurogenesis and memory are highly energy-demanding processes that rely on healthy mitochondria and good blood-flow signaling. This proof-of-concept study shows that (−)-epicatechin can stimulate these pathways, helping the brain maintain its natural ability to form new connections. Supporting mitochondrial health is a practical way to keep these energy-dependent mechanisms working efficiently throughout life.

    Related Content

    View Paper

    Brain Protein Structure and Cellular Stability

    Study Title:
    Effects of (−)-epicatechin on frontal cortex DAPC and dysbindin of the mdx mice

    Citation:
    Estrada-Mena et al., 2017. Neuroscience Letters

    What the Study Found:
    In mdx mice, (−)-epicatechin treatment partially restored key components of the dystrophin-associated protein complex (DAPC) and improved dysbindin levels in the frontal cortex. It also strengthened protein interactions within this complex. These changes indicate greater structural stability in brain cells that are typically disrupted in this model.

    What this means in real life:
    When mitochondrial energy production is compromised, brain cells can lose the structural scaffolding they need to function properly. This study shows that (−)-epicatechin helps restore important protein complexes in the frontal cortex, supporting the cellular stability that depends on healthy mitochondrial function. At Mitozz we focus on mitochondrial health because even small improvements in cellular energy can help protect brain tissue under stress.

    Related Content

    View Paper

    Epicatechin and Breast Cancer Cell Migration in Vitro

    Study Title: (−)-Epicatechin inhibits metastatic-associated proliferation, migration, and invasion of murine breast cancer cells in vitro

    Citation: Pérez-Durán et al., 2023 · Molecules

    What the Study Found: This in vitro study evaluated the effects of (-)-epicatechin on murine breast cancer cells, focusing on behaviors associated with metastatic potential. The researchers reported that (-)-epicatechin reduced cell proliferation and decreased migration and invasion in experimental assays. The paper also examined molecular signals related to epithelial-mesenchymal transition and matrix remodeling, including changes in markers such as vimentin, E-cadherin, and MMP-9. These findings suggest that (-)-epicatechin influenced several cell behaviors and signaling markers linked to cancer-cell movement in this laboratory model.

    What this means in real life: This study is useful because it looks beyond general antioxidant language and examines specific cancer-cell behaviors in a controlled laboratory setting. The results suggest that (-)-epicatechin may affect pathways related to proliferation, migration, invasion, and cell phenotype in murine breast cancer cells. This does not mean (-)-epicatechin treats, prevents, or slows breast cancer in humans. The findings are preclinical and should be understood as early mechanistic evidence that requires much more research before any clinical conclusions can be made.

    Clinical Relevance: In vitro murine breast cancer cell study, focused on proliferation, migration, invasion, epithelial-mesenchymal transition markers, and metastatic-associated behavior.

    Related Content:

    View Paper

    Epicatechin and Triple-Negative Breast Cancer Tumor Growth in Mice

    Study Title: Anticancer potential of (−)-epicatechin in a triple-negative mammary gland model

    Citation: Almaguer et al., 2021 · Journal of Pharmacy and Pharmacology

    What the Study Found: This study evaluated (-)-epicatechin in a mouse model of triple-negative mammary gland cancer using 4T1 breast cancer cells in female BALB/c mice. The researchers reported that (-)-epicatechin reduced tumor growth, with 2 and 3 mg/kg/day doses showing effects comparable to doxorubicin in this model. The study also found improved survival in (-)-epicatechin-treated animals compared with controls. Mechanistically, the authors reported changes in AMPK phosphorylation, Akt phosphorylation, and mTOR expression, suggesting that (-)-epicatechin may influence pathways involved in tumor-cell proliferation.

    What this means in real life: This paper is relevant because it examines (-)-epicatechin in an animal model of an aggressive breast cancer subtype, while also looking at signaling pathways tied to cell growth and metabolism. The results are preclinical and should not be interpreted as evidence that (-)-epicatechin treats, prevents, or slows breast cancer in humans. The practical takeaway is narrower: this study adds to early mechanistic research on how (-)-epicatechin may affect tumor biology in controlled experimental models.

    Clinical Relevance: Mouse triple-negative mammary gland cancer model, tumor growth and survival endpoints, AMPK and Akt/mTOR signaling; not human clinical evidence.

    Related Content:

    View Paper

    Continue Exploring Mitochondrial Science

    Mitochondria 101  |  Visit Our Blog  |  Join the Community